Farmer's lung: thermophilic actinomycetes as a source of "farmer's lung hay" antigen. 1963

J Pepys1, P A Jenkins, G N Festenstein

  • 1Department of Medicine, Institute of Diseases of the Chest, Brompton, London.

Allergy Proceedings : the Official Journal of Regional and State Allergy Societies
|March 1, 1990
PubMed

Insights

Farmer's lung hay (F.L.H.) antigen can be produced in laboratory conditions using specific microorganisms, particularly Thermopolyspora polyspora. Inhalation of F.L.H. antigen triggers farmer's lung symptoms, highlighting its role in the disease.

Area of Science:

  • Immunology
  • Microbiology
  • Environmental Health

Background:

  • Farmer's lung is a hypersensitivity pneumonitis caused by inhaling dust contaminated with thermophilic actinomycetes.
  • Identifying the specific antigens responsible for farmer's lung is crucial for diagnosis and prevention.
  • Laboratory production of farmer's lung hay (F.L.H.) antigen aids in understanding disease pathogenesis.

Discussion:

  • F.L.H. antigen production in hay is optimized by specific microbial inoculations and controlled pH conditions.
  • Thermopolyspora polyspora and Micromonospora vulgaris are identified as significant sources of F.L.H. antigen.
  • Fungal inoculation alone or with certain actinomycetes did not yield F.L.H. antigen, but some sera reacted to fungal antigens.

Key Insights:

  • Thermopolyspora polyspora is the most potent source of F.L.H. antigen identified, capable of producing it in pure culture.
  • Spores and mycelium of T. polyspora are rich in F.L.H. antigen, suggesting inhaled spores are a primary etiological factor.
  • Experimental inhalation of F.L.H. antigen extract in affected subjects reproduced key farmer's lung symptoms.

Outlook:

  • Further research into other actinomycetes may reveal additional sources of farmer's lung antigens.
  • Understanding antigen production mechanisms can lead to improved diagnostic tools and preventative strategies.
  • Investigating the role of pure microbial cultures in antigenicity could inform therapeutic interventions.